Research and engagement considerations for alcohol use telehealth services within HIV care: a qualitative exploration in federally qualified health centers

AIDS Care. 2023 Nov;35(11):1786-1795. doi: 10.1080/09540121.2023.2197640. Epub 2023 Apr 11.

Abstract

The prevalence of alcohol misuse is high among people with HIV (PWH); however, access to and utilization of evidence-based alcohol misuse interventions remain limited. Telehealth is one treatment approach with the potential for enhancing substance use disorder treatment utilization for PWH served by Federally Qualified Health Centers (FQHCs). However, questions remain regarding barriers to alcohol-focused telehealth service integration and telehealth research in FQHCs. This study employed qualitative methods, guided by the Dynamic Sustainability Framework, to evaluate barriers and cultural factors impacting FQHC telehealth integration. Eighteen qualitative interviews were completed with staff and leaders across four FQHCs. Interviews were analyzed using directed content analysis, and codes were organized into a priori and emergent themes. Key themes included the presence of common workflows for referring clients to substance use disorder treatment; existing research workflows and preferences for active project staff involvement; telehealth barriers including exacerbation of healthcare disparities and high provider turnover; and the importance of cultural humility and telehealth adaptations for sexual, gender, racial and ethnic minority clients. Findings from this study will inform the development of an alcohol-focused telehealth implementation strategy for a Hybrid Type 1 implementation effectiveness trial to enhance FQHC substance use disorder treatment.Trial registration: ClinicalTrials.gov identifier: NCT02563574..

Keywords: HIV; Telehealth intervention; alcohol misuse; alcohol use disorder; implementation science; qualitative methods.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Alcoholism* / therapy
  • Clinical Trials as Topic
  • Ethnicity
  • Female
  • HIV Infections* / therapy
  • Humans
  • Male
  • Minority Groups
  • Telemedicine* / methods

Associated data

  • ClinicalTrials.gov/NCT02563574